Juanjie Bo

916 citations
24 papers · 679 indexed · h-index 14
Topics
Bladder and Urothelial Cancer Treatments (7 papers)Urinary and Genital Oncology Studies (3 papers)Immune cells in cancer (3 papers)

In The Last Decade

Juanjie Bo

24 papers receiving 668 citations

Peers

Juanjie Bo
Comparison fields: 5 of 69
  • Molecular Biology 375
  • Cancer Research 200
  • Oncology 176
  • Surgery 162
  • Immunology 138
Replace Gayani Pitiyage with:
Gayani Pitiyage United Kingdom
Maryam Moradi Binabaj Iran
Da Wu China
Chen Zong China
Xinxin Bu China
Christina Wunrau Germany
Eduard Sarró Spain
Xueyou Ma China
Juanjie Bo relative to Gayani Pitiyage United Kingdom Gayani Pitiyage's profile →
Citations per field
00.5×1.5×1.8×
Gayani Pitiyage · 1×
Citations per year

Countries citing papers authored by Juanjie Bo

Since Specialization
Citations

This map shows the geographic impact of Juanjie Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juanjie Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juanjie Bo more than expected).

Fields of papers citing papers by Juanjie Bo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juanjie Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juanjie Bo. The network helps show where Juanjie Bo may publish in the future.

Co-authorship network of co-authors of Juanjie Bo

This figure shows the co-authorship network connecting the top 25 collaborators of Juanjie Bo. A scholar is included among the top collaborators of Juanjie Bo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juanjie Bo. Juanjie Bo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 78
2 14
3 7
4 3
5 56
6 89
7 8
8 42
9 11
10 27
11 18
12 2
13 27
14 70
15 4
16
Expression of Ki67 Protein in Non-muscle-invasive Bladder Cancer and its Significance
1
17 29
18 15
19 85
20
[Combination of tamsulosin and tolterodine alleviates refractory lower urinary tract symptoms in male patients].
2

About Juanjie Bo

Juanjie Bo is a scholar working on Urology, Immunology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 679 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Cancer Research (200 citations), Immunology (138 citations) and Oncology (176 citations). Juanjie Bo has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Guoliang Yang, Yong Huang, Dongming Liu, Lianhua Zhang, Mengyao Liu, Jianjun Sha, Lianhua Zhang, Ming Cao, Haifeng Jiang and Haige Chen. Their work appears in journals such as International Journal of Cancer, Clinica Chimica Acta and FEBS Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026